Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

Europe patent application withdrawn as of 10/30/2013 because Radient did not pay the annual renewal fee.

If UNI gets the manufacturing processes in place, they can sell in Europe.

https://register.epo.org/application?number=EP09789550

EP2414843 - DETECTION OF FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS AND ASSOCIATED METHODS OF PRODUCTION AND USE FOR THE DETECTION AND MONITORING OF CANCER [ Right-click to bookmark this link ]

Entry into regional phase
18.10.2011 National basic fee paid
18.10.2011 Designation fee(s) paid
18.10.2011 Examination fee paid
Examination procedure
18.10.2011 Examination requested [2012/06]
18.05.2012 Amendment by applicant (claims and/or description)
10.09.2013 Despatch of a communication from the examining division (Time limit: M04)
30.10.2013 Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time

I notice that India (IN) was not covered by Europe Patent App... hard to figure out the status of IN
************88